Molecular Insight Pharmaceuticals, Inc.
160 Second Street, Cambridge, MA 02142
617.492.5554 tel :: 617.492.5664 fax
info@molecularinsight.com

Press Releases

2013

01/22/13
Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline

 

2012

09/24/12
Molecular Insight Announces Initiation of Phase 2 Trial for Prostate Cancer Molecular
Imaging Drug

06/14/12
Molecular Insight Pharmaceuticals, Inc. Presents Clinical Oncology Data at Society of Nuclear Medicine 2012 Annual Meeting

02/23/12
Molecular Insight Pharmaceuticals, Inc. Elects a New Board of Directors

02/02/12
Molecular Insight Pharmaceuticals, Inc. Presents Human Data Demonstrating Detection of Metastatic Prostate Cancer

01/30/12
Radiopharmaceutical for Targeted Treatment of Prostate Cancer to Enter Clinical Trials

 

2011

10/19/11
Molecular Insight Pharmaceuticals, Inc. Presents Positive Cancer Data at the Annual Congress of the European Association of Nuclear Medicine

07/07/11
Molecular Insight Pharmaceuticals’ Trofex Data Published in Journal of Nuclear Medicine

06/13/11
Molecular Insight Pharmaceuticals Presents Oncology Data at Society of Nuclear Medicine 2011 Annual Meeting